ArticleCancer2018
Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?
Ahmet Emre EskazanPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it